Back
Akebia Therapeutics Vs. Masimo Industry Stock Comparison
Sell
36
AKBA
Akebia Therapeutics
Last Price:
1.37
Seasonality Move:
-2.71%
Buy
58
MASI
Masimo
Last Price:
121.39
Seasonality Move:
4.25%
Sell
36
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.37. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Masimo (MASI)
is a Buy
Is Masimo a Buy, Sell or Hold?
- The current Masimo [MASI] share price is $121.36. The Score for MASI is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- MASI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.37
The current trend is moderately bearish and AKBA is experiencing slight buying pressure.
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 46.8 | Sell |
Chaikin Money Flow: | 264579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.39 - 1.51) | Sell |
Bollinger Bands (100): | (1.07 - 1.43) | Buy |
MASI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 60 | Buy |
Chaikin Money Flow: | 1349818 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.89 - 120.43) | Buy |
Bollinger Bands (100): | (111.17 - 129.21) | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.4 | Sell |
20-day SMA: | 1.44 | Sell |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 1.37 | Buy |
8-day EMA: | 1.39 | Sell |
20-day EMA: | 1.41 | Sell |
50-day EMA: | 1.36 | Buy |
200-day EMA: | 1.3 | Buy |
MASI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 114.55 | Buy |
20-day SMA: | 115.19 | Buy |
50-day SMA: | 114.9 | Buy |
200-day SMA: | 124.13 | Sell |
8-day EMA: | 115.34 | Buy |
20-day EMA: | 115.54 | Buy |
50-day EMA: | 116.92 | Buy |
200-day EMA: | 122 | Sell |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Masimo Earnings Growth & MASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $0.39 per share, and an increase next year of $0.45 per share.
Akebia Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Masimo Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |